
Sign up to save your podcasts
Or
Ignacio Duran joins the show to discuss the landscape of established ADCs in urothelial cancer and challenges of drug development in this setting.
4.9
5555 ratings
Ignacio Duran joins the show to discuss the landscape of established ADCs in urothelial cancer and challenges of drug development in this setting.
4,222 Listeners
4,314 Listeners
31,952 Listeners
3,461 Listeners
22,154 Listeners
43,308 Listeners
9,272 Listeners
314 Listeners
744 Listeners
2 Listeners
2,126 Listeners
616 Listeners
1,428 Listeners
166 Listeners